These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17163811)

  • 1. Zonisamide for bipolar depression.
    Wilson MS; Findling RL
    Expert Opin Pharmacother; 2007 Jan; 8(1):111-3. PubMed ID: 17163811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preliminary open-label study of zonisamide treatment for bipolar depression in 10 patients.
    Anand A; Bukhari L; Jennings SA; Lee C; Kamat M; Shekhar A; Nurnberger JI; Lightfoot J
    J Clin Psychiatry; 2005 Feb; 66(2):195-8. PubMed ID: 15705004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
    McElroy SL; Suppes T; Keck PE; Black D; Frye MA; Altshuler LL; Nolen WA; Kupka RW; Leverich GS; Walden J; Grunze H; Post RM
    J Clin Psychiatry; 2005 May; 66(5):617-24. PubMed ID: 15889949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.
    Kanba S; Yagi G; Kamijima K; Suzuki T; Tajima O; Otaki J; Arata E; Koshikawa H; Nibuya M; Kinoshita N
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):707-15. PubMed ID: 7938561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
    Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
    J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open prospective study of zonisamide in acute bipolar depression.
    Ghaemi SN; Zablotsky B; Filkowski MM; Dunn RT; Pardo TB; Isenstein E; Baldassano CF
    J Clin Psychopharmacol; 2006 Aug; 26(4):385-8. PubMed ID: 16855456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zonisamide-induced psychosis in a patient with bipolar disorder and narcolepsy.
    Platt JE; Opler LA; Platt EM
    Am J Ther; 2014; 21(3):e88-9. PubMed ID: 22713527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
    Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
    Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE
    J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive zonisamide for weight loss in euthymic bipolar disorder patients: a pilot study.
    Wang PW; Yang YS; Chandler RA; Nowakowska C; Alarcon AM; Culver J; Ketter TA
    J Psychiatr Res; 2008 May; 42(6):451-7. PubMed ID: 17628595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer anticonvulsants in the treatment of bipolar disorder.
    Yatham LN
    J Clin Psychiatry; 2004; 65 Suppl 10():28-35. PubMed ID: 15242330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide treatment of bipolar disorder: a case report.
    Berigan TR
    Can J Psychiatry; 2002 Nov; 47(9):887. PubMed ID: 12500762
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain.
    McElroy SL; Winstanley E; Mori N; Martens B; McCoy J; Moeller D; Guerdjikova AI; Keck PE
    J Clin Psychopharmacol; 2012 Apr; 32(2):165-72. PubMed ID: 22367654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Zonisamide for the Treatment of Psychiatric Disorders: A Systematic Review.
    Buoli M; Grassi S; Ciappolino V; Serati M; Altamura AC
    Clin Neuropharmacol; 2017; 40(2):85-92. PubMed ID: 28195838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cautionary note when using zonisamide in youths: a case report of association with toxic epidermal necrolysis.
    Majeres KD; Suppes T
    J Clin Psychiatry; 2004 Dec; 65(12):1720. PubMed ID: 15641880
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
    Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
    J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide-induced depression and mania in patients with epilepsy.
    Ozawa K; Kobayashi K; Noda S; Iyo M
    J Clin Psychopharmacol; 2004 Feb; 24(1):110-1. PubMed ID: 14709966
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial.
    Iwata Y; Irie S; Uchida H; Suzuki T; Watanabe K; Iwashita S; Mimura M
    J Neurol Sci; 2012 Apr; 315(1-2):137-40. PubMed ID: 22285275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.